Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia
Clinical trial NCT07033481 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07033481
- Sponsor
- EIP Pharma Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-02
- Primary completion
- 2026-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.